Kuros Biosciences AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kuros Biosciences AG with three other
miscellaneous service companies in Europe:
Silence Therapeutics Plc
of the United Kingdom
sales of £770,000.00 [US$1.10 million]
Oryzon Genomics Sa
(735,312.00 Euro [US$910,036.84 ]
Realm Therapeutics PLC
based in the United Kingdom
(£644,819.07 [US$921,169.18 ]
of which 100%
was Health Sciences).
Sales fell dramatically in 2016:
During the year ended December of 2016, sales at
Kuros Biosciences AG were 1.06 million Swiss Francs (US$1.10 million).
decrease of 83.3%
versus 2015, when the company's sales were 6.36 million Swiss Francs.